top
Search terms
Results 1 - 10 of 235 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 24
Ehjournal

Mark Nicholls reports on the implications for heart failure patients in using the LivaNova SonR system for cardiac resynchronisation therapy Echo-guided resynchronization is recognized as the gold ...

European Heart Journal, CardioPulse

Date : 01/11/2016 Item size : 122110 bytes
Ehjournal

The HFA Congress featured alongside the release of the new HFA/ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, the presentation of the European Guidelines on ...

European Heart Journal, CardioPulse

Date : 01/11/2016 Item size : 127830 bytes
Ehjournal

In spite of recent progress made in the management of heart failure as outlined in current guidelines,1 patients often remain symptomatic, and the event rate, even on optimal therapy and with ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 14/03/2015 Item size : 212048 bytes
Ehjournal

João Pedro Ferreira 1INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France2Department of ...

European Heart Journal, Review, João Pedro Ferreira, Nicolas Girerd, Saleh Alshalash, Marvin A. Konstam, Faiez Zannad

Date : 14/08/2016 Item size : 194590 bytes
Ehjournal

[...]to address this issue, the European Society of Cardiology has started a special journal on this subject this year, namely the EHJ Quality of Care and Clinical Outcomes, under the leadership of ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 01/01/2016 Item size : 243077 bytes
Ehjournal

The first cells to be utilised in clinical trials in cardiovascular disease were autologous bone marrow-derived mononuclear cells (ABMMNCs).13 This was likely due to the fact that these cells are ...

European Heart Journal, Editorial, James T. Willerson, Maria G. Cabreira-Hansen, Doris A. Taylor, Emerson C. Perin

Date : 14/07/2015
Ehjournal

Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program Methods and results We studied 7599 patients enrolled in the candesartan ...

European Heart Journal, CLINICAL RESEARCH, Ali Vazir, Brian Claggett, Pardeep Jhund, Davide Castagno, Hicham Skali, Salim Yusuf, Karl Swedberg, Christopher B. Granger, John J.V. McMurray, Marc A. ...

Date : 14/03/2015
Ehjournal

Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled ...

European Heart Journal, FASTTRACK CLINICAL RESEARCH, Elke S. Hoendermis, Licette C.Y. Liu, Yoran M. Hummel, Peter van der Meer, Rudolf A. de Boer, Rolf M.F. Berger, Dirk J. van Veldhuisen, Adriaan A. ...

Date : 07/10/2015
Ehjournal

ATMOSPHERE failed to show benefit in heart failure patients with diabetes A subgroup analysis in heart failure patients with diabetes from the Aliskiren Trial of Minimizing OutcomeS for Patients with ...

European Heart Journal, Tofield, Andros

Date : 01/02/2017 Item size : 78946 bytes